Transplantation of hematopoietic stem cells (HSCs) has been successfully developed as a
part of treatment protocols for a large number of clinical indications, and cryopreservation of …

Transplantation of hematopoietic progenitor cells from red cell-incompatible donors occurs
in 30–50% of patients. Immediate and delayed hemolytic transfusion reactions are expected …

PURPOSE: To compare hematologic recovery in patients receiving allogeneic blood cell
transplantation (BCT) with those receiving allogeneic bone marrow transplantation (BMT) …

Immune haemolysis as a result of minor ABO incompatibility is an underappreciated
complication of haematopoietic transplantation. The increased lymphoid content of …

Probes on the basic nursing care during the infusion of hematopoietic progenitor cells.
Focus on the infusion of autologous bone marrow and PBPCS transplantation; Description …

Immune hemolysis is one of the adverse effects that can occur following hematopoietic cell
or solid organ transplantation. Understanding the clinical settings and the various causes of …

Transplantation between red cell-disparate donor and recipient is feasible with minimal
increase in the risk of transplantation if consideration is given to the immunohematological …

The article offers information on dealing with ABO blood group antigens incompatibility
hematopoietic progenitor cell (HPC) transplantation. It is said that for a successful HPC …

BACKGROUND: Immune‐mediated hemolysis is a well‐recognized complication of
transplantation, but few reports have drawn together the different mechanisms that could be …

BACKGROUND: ABO mismatch has not been thought to affect the outcome of patients
undergoing myeloablative conditioning and allogeneic HPC transplantation. Data on …